CLINICAL_TRIALS
research
· 2026-04-09
Clinical Trial Update: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation [Phase 3]
Summary
A Phase 3 clinical trial evaluating rhythm evaluation for anticoagulation with continuous monitoring in atrial fibrillation is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johns Hopkins University | Conditions: Atrial Fibrillation | Phase 3 | Status: RECRUITING